XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.3

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2025

Fair Value Disclosures [Abstract]

Schedule of Changes in Fair Value of Outstanding Warrant and Tranche Liabilities

The following tables summarize the changes in fair value of our outstanding warrant liabilities, contingent earnout liability, SEPA liability and revenue base redemption liability for the nine months ended September 30, 2025:

Warrant Liabilities						Fair Value at December 31, 2024						Change in Unrealized (Gains) Losses						Issuances (Settlements)						Fair Value at September 30, 2025
Public Warrants - Level 1						$	1,927					$	1,051					$	—					$	2,978
Private Placement Warrants - Level 2						4,872						2,657						—						7,529
Working Capital Warrants - Level 2						1,100						600						—						1,700
Total						$	7,899					$	4,308					$	—					$	12,207

Level 3 Liabilities						Fair Value at December 31, 2024						Change in Unrealized (Gains) Losses						Issuances (Settlements)												Fair Value at September 30, 2025
Contingent earnout liability						$	7,401					$	(2,404)					$	—											$	4,997
SEPA liability						$	55					$	(55)					$	—											$	—
OrbiMed Warrants liability						$	362					$	(151)					$	366											$	577
Revenue base redemption liability						$	507					$	(5)					$	—											$	502

The following tables summarize the changes in fair value of our outstanding warrant liabilities, contingent earnout liability, SEPA liability, and revenue base redemption liability for the nine months ended September 30, 2024:

Warrant Liabilities						Fair Value at December 31, 2023						Change in Unrealized (Gains) Losses						Issuances (Settlements)						Fair Value at September 30, 2024
Public Warrants - Level 1						$	9,855					$	2,982					$	(11,068)					$	1,769
Private Placement Warrants - Level 2						5,871						(542)						(855)						4,474
Working Capital Warrants - Level 2						1,190						(180)						—						1,010
Total						$	16,916					$	2,260					$	(11,923)					$	7,253

Level 3 Liabilities						Fair Value at December 31, 2023						Change in Unrealized (Gains) Losses						Issuances (Settlements)												Fair Value at September 30, 2024
Contingent earnout liability						$	18,632					$	(12,061)					$	—											$	6,571
SEPA liability						$	185					$	51					$	—											$	236
Initial OrbiMed Warrant liability						$	—					$	(488)					$	811											$	323
Revenue base redemption liability						$	—					$	(303)					$	729											$	426

X

- References

No definition available.

+ Details

Name:	us-gaap_FairValueDisclosuresAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration